Mechanisms and treatment of the "afternoon phenomenon" in patients with type 1 diabetes mellitus using glargine as basal insulin

被引：0
|
作者：
Rossetti, P
Porcellati, F
Fanelli, CG
Bolli, GB
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [1] Mechanisms and treatment of the "afternoon phenomenon" in patients with type 1 diabetes mellitus using glargine as basal insulin
    Rossetti, P
    Porcellati, F
    Fanelli, CG
    Bolli, GB
    DIABETOLOGIA, 2005, 48 : A328 - A328
  • [2] Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus: Using insulin glargine as basal insulin
    Kawamori, Ryuzo
    Kadowaki, Takashi
    Ishii, Hitoshi
    Iwasaki, Manabu
    Iwamoto, Yasuhiko
    DIABETES, 2008, 57 : A573 - A573
  • [3] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
  • [4] Effect of exercise on Pharmacokinetics (PK) of Basal Insulin peglispro (BIL) and insulin Glargine (GL) in type 1 diabetes mellitus patients
    Linnebjerg, H.
    Lam, E.
    Choi, S.
    Knadler, M. P.
    Porksen, N.
    Sinha, V. P.
    Garhyan, P.
    Klein, O.
    Nosek, L.
    Heise, T.
    DIABETOLOGIA, 2015, 58 : S164 - S164
  • [5] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Moock, J.
    Hessel, F.
    Kohlmann, T.
    VALUE IN HEALTH, 2008, 11 (06) : A514 - A514
  • [6] COMPARATIVE CLINICAL EFFICACY OF INSULIN GLARGINE ANALOGUE FOR TREATMENT OF PATIENTS AFFECTED BY DIABETES MELLITUS TYPE 1
    Oliveira, G. C.
    Melo, L. M.
    Guerra Junior, A. A.
    AcurcioFd
    Alvares, J.
    VALUE IN HEALTH, 2015, 18 (07) : A862 - A863
  • [7] Observational Study of the Use of Insulin Glargine as Basal Therapy in Patients With Type 2 Diabetes Mellitus in Morocco
    Chraibi, Abdelmjid
    Iraqi, Hinde
    Seqat, Mehdi
    El Achhab, Youness
    Nejjari, Chakib
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 5 (06) : 333 - 336
  • [8] ECONOMIC ANALYSIS OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Acevedo, G. A. R.
    VALUE IN HEALTH, 2009, 12 (07) : A408 - A409
  • [9] Insulin glargine provides basal insulin requirements in the management of diabetes mellitus
    不详
    Drugs & Therapy Perspectives, 2002, 18 (7) : 7 - 9
  • [10] Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus
    Wang, Weimin
    Song, Xiang
    Lou, Ying
    Du, Liying
    Zhu, Dalong
    Zhou, Zhiguang
    DIABETES OBESITY & METABOLISM, 2022, 24 (06): : 1094 - 1104
12345